Elevated levels of specific KLKscorrelate with poor prognosis in many cancer types,2 notably KLK3 (or prostate-specific antigen, PSA) whichis a biomarker for prostate cancer diagnosis and treatment monitoring,with recent reports also revealing important roles for KLK2 and KLK14.3−5. Here, KLK3 is linked to prostate cancer.